A phase I study to determine the safety, tolerability and maximum tolerated dose of green-lipped mussel (Perna canaliculus) lipid extract, in patients with advanced prostate and breast cancer

Shawgi Sukumaran, Ken Pittman, W Patterson, J Dickson, S Yeend, Amanda Townsend, Vy Broadbridge, Timothy Price

    Research output: Contribution to journalArticle

    6 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1089-1093
    Number of pages5
    JournalAnnals of Oncology
    Volume21
    Issue number5
    Publication statusPublished - 2009

    Cite this

    Sukumaran, S., Pittman, K., Patterson, W., Dickson, J., Yeend, S., Townsend, A., Broadbridge, V., & Price, T. (2009). A phase I study to determine the safety, tolerability and maximum tolerated dose of green-lipped mussel (Perna canaliculus) lipid extract, in patients with advanced prostate and breast cancer. Annals of Oncology, 21(5), 1089-1093.